All Stories

  1. Exhaled volatile organic compounds for better asthma control: could it be a future noninvasive adherence test?
  2. Characteristics of severe asthmatics treated with omalizumab, mepolizumab or no biotherapy. Data from the Belgian Severe Asthma Registry (BSAR)
  3. It needs more than just eosinophils to cause emphysema in COPD
  4. Reduced sputum expression of interferon-stimulated genes in severe COPD
  5. Blood eosinophil count to predict bronchial eosinophilic inflammation in COPD
  6. Diabète insipide dans le cadre d’un carcinome pulmonaire à petites cellules : un paradoxe ?